Unknown

Dataset Information

0

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.


ABSTRACT: Blockade of colony-stimulating factor-1 (CSF-1) limits macrophage infiltration and improves response of mammary carcinomas to chemotherapy. Herein we identify interleukin (IL)-10 expression by macrophages as the critical mediator of this phenotype. Infiltrating macrophages were the primary source of IL-10 within tumors, and therapeutic blockade of IL-10 receptor (IL-10R) was equivalent to CSF-1 neutralization in enhancing primary tumor response to paclitaxel and carboplatin. Improved response to chemotherapy was CD8(+) T cell-dependent, but IL-10 did not directly suppress CD8(+) T cells or alter macrophage polarization. Instead, IL-10R blockade increased intratumoral dendritic cell expression of IL-12, which was necessary for improved outcomes. In human breast cancer, expression of IL12A and cytotoxic effector molecules were predictive of pathological complete response rates to paclitaxel.

SUBMITTER: Ruffell B 

PROVIDER: S-EPMC4254570 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

Ruffell Brian B   Chang-Strachan Debbie D   Chan Vivien V   Rosenbusch Alexander A   Ho Christine M T CM   Pryer Nancy N   Daniel Dylan D   Hwang E Shelley ES   Rugo Hope S HS   Coussens Lisa M LM  

Cancer cell 20141016 5


Blockade of colony-stimulating factor-1 (CSF-1) limits macrophage infiltration and improves response of mammary carcinomas to chemotherapy. Herein we identify interleukin (IL)-10 expression by macrophages as the critical mediator of this phenotype. Infiltrating macrophages were the primary source of IL-10 within tumors, and therapeutic blockade of IL-10 receptor (IL-10R) was equivalent to CSF-1 neutralization in enhancing primary tumor response to paclitaxel and carboplatin. Improved response to  ...[more]

Similar Datasets

| S-EPMC10252493 | biostudies-literature
| S-EPMC6225717 | biostudies-literature
| S-EPMC10613395 | biostudies-literature
| S-EPMC6287797 | biostudies-other
| S-EPMC4298783 | biostudies-literature
| S-EPMC5673935 | biostudies-literature
2013-06-21 | E-GEOD-37739 | biostudies-arrayexpress
2013-06-21 | GSE37739 | GEO
| S-EPMC5225035 | biostudies-literature
| S-EPMC3436124 | biostudies-literature